BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15166506)

  • 1. Melanocytes express 3G5 surface antigen.
    Fiedler E; Nayak RC; Marsch WCh; Helmbold P
    Am J Dermatopathol; 2004 Jun; 26(3):200-4. PubMed ID: 15166506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
    Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
    Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative activity of primary cutaneous melanocytic tumours.
    Kuwata T; Kitagawa M; Kasuga T
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):359-64. PubMed ID: 7906909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferentially Expressed Antigen in Melanoma Immunostaining in a Series of Melanocytic Neoplasms.
    Googe PB; Flanigan KL; Miedema JR
    Am J Dermatopathol; 2021 Nov; 43(11):794-800. PubMed ID: 33989214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of growth hormone receptor in benign and malignant cutaneous proliferative entities.
    Ginarte M; García-Caballero T; Fernández-Redondo V; Beiras A; Toribio J
    J Cutan Pathol; 2000 Jul; 27(6):276-82. PubMed ID: 10885403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UV-irradiated melanocytic nevi simulating melanoma in situ.
    Tronnier M; Wolff HH
    Am J Dermatopathol; 1995 Feb; 17(1):1-6. PubMed ID: 7695003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staining of melanocytic neoplasms by melanoma antigen recognized by T cells.
    Mehregan DR; Hamzavi I
    Am J Dermatopathol; 2000 Jun; 22(3):247-50. PubMed ID: 10871068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
    Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
    J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro-anatomy related antigen expression in melanocytic lesions.
    Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
    J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes.
    Gown AM; Vogel AM; Hoak D; Gough F; McNutt MA
    Am J Pathol; 1986 May; 123(2):195-203. PubMed ID: 3518473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melan-A positive dermal cells in malignant melanoma in situ.
    Danga ME; Yaar R; Bhawan J
    J Cutan Pathol; 2015 Jun; 42(6):388-93. PubMed ID: 25726939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
    Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
    Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of proliferating cell nuclear antigen (PCNA): proliferative phase functions and malignant transformation of melanocytes.
    Iyengar B
    Melanoma Res; 1994 Oct; 4(5):293-5. PubMed ID: 7858412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression Pattern of Aquaporin 1 and Aquaporin 3 in Melanocytic and Nonmelanocytic Skin Tumors.
    Osorio G; Zulueta-Dorado T; González-Rodríguez P; Bernabéu-Wittel J; Conejo-Mir J; Ramírez-Lorca R; Echevarría M
    Am J Clin Pathol; 2019 Sep; 152(4):446-457. PubMed ID: 31305898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A histopathological study of melanocytic and pigmented skin lesions in patients with albinism.
    van der Westhuizen G; Beukes CA; Green B; Sinclair W; Goedhals J
    J Cutan Pathol; 2015 Nov; 42(11):840-6. PubMed ID: 26268889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Triggered trap": nevoid malignant melanoma.
    McNutt NS
    Semin Diagn Pathol; 1998 Aug; 15(3):203-9. PubMed ID: 9711670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common phenotypic expression of gangliosides GM3 and GD3 in normal human tissues and neoplastic skin lesions.
    Nakakuma H; Horikawa K; Kawaguchi T; Hidaka M; Nagakura S; Hirai S; Kageshita T; Ono T; Kagimoto T; Iwamori M
    Jpn J Clin Oncol; 1992 Oct; 22(5):308-12. PubMed ID: 1469793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
    Kopera D; Hohenleutner U; Stolz W; Landthaler M
    Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 expression in melanocytic lesions of the skin.
    Ramirez JA; Guitart J; Rao MS; Diaz LK
    Ann Diagn Pathol; 2005 Aug; 9(4):185-8. PubMed ID: 16084449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.